✦ LIBER ✦

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

✍ Scribed by Daniel Bloomfield; Gary L. Carlson; Aditi Sapre; Diane Tribble; James M. McKenney; Thomas W. Littlejohn III; Christine McCrary Sisk; Yale Mitchel; Richard C. Pasternak

Book ID: 116191611
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 450 KB
Volume: 157
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2008.09.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EFFICACY AND SAFETY OF THE CHOLESTERYL E

EFFICACY AND SAFETY OF THE CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR ANACETRAPIB AS MONOTHERAPY AND COADMINISTERED WITH ATORVASTATIN IN JAPANESE PATIENTS WITH DYSLIPIDEMIA

✍ Teramoto, Tamio; Numaguchi, Hirotaka; Shirakawa, Masayoshi; Kikuchi, Masashi; Na 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Efficacy and safety of the cholesteryl e

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia

✍ Teramoto, Tamio; Shirakawa, Masayoshi; Kikuchi, Masashi; Nakagomi, Mariko; Tamur 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 379 KB

Efficacy and safety after cessation of t

Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia

✍ Hayes M. Dansky; Daniel Bloomfield; Patrice Gibbons; Sherry Liu; Christine McCra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Evaluation of Lipids, Drug Concentration

Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

✍ Gotto, Antonio M.; Cannon, Christopher P.; Li, Xiujiang Susie; Vaidya, Sanskruti 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Efficacy and Safety of Torcetrapib, a No

Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density Lipoprotein Cholesterol Levels

✍ Michael H. Davidson; James M. McKenney; Charles L. Shear; James H. Revkin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 534 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB